Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12571587 | Finishing apparatus for a spray drying system | 🖼🧊📄§ | 2026-03-10 | 2043-09-14 | 0 | 31 |
| 12569576 | Compositions and methods for measuring oxidative stress | 🖼🧊📄§ | 2026-03-10 | 2041-06-10 | 0 | 31 |
| 12569513 | Stable, highly pure L-cysteine compositions for injection and methods of use | 🖼🧊📄§ | 2026-03-10 | 2044-12-24 | 0 | 31 |
| 12569518 | Cartilage tissue | 🖼🧊📄§ | 2026-03-10 | 2040-02-07 | 0 | 31 |
| 12569567 | Retinoic acid modified lysosome targeting chimera molecule, preparation method and applications thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-16 | 0 | 31 |
| 12570757 | Antibodies against the poliovirus receptor (PVR) and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-10-07 | 0 | 31 |
| 12569422 | Composition and method of inhibiting cortisone reductase by applying it to the skin | 🖼🧊📄§ | 2026-03-10 | 2039-10-10 | 0 | 31 |
| 12571800 | Means and methods for treating angiogenesis-related diseases | 🖼🧊📄§ | 2026-03-10 | 2042-10-14 | 0 | 31 |
| 12570966 | Mutated PIGGYBAC® transposase | 🖼🧊📄§ | 2026-03-10 | 2039-12-09 | 0 | 31 |
| 12570735 | Compositions and methods for treating inflammasome related diseases or conditions | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12570605 | Indole compounds, and preparation methods, and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-02 | 0 | 31 |
| 12570606 | Myeloperoxidase imaging agents | 🖼🧊📄§ | 2026-03-10 | 2042-04-29 | 0 | 31 |
| 12570687 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | 🖼🧊📄§ | 2026-03-10 | 2040-09-14 | 0 | 31 |
| 12570689 | Purification of GLP-1 analogues | 🖼🧊📄§ | 2026-03-10 | 2040-02-05 | 0 | 31 |
| 12570694 | Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12570708 | Recombinant proteins and their therapeutic uses | 🖼🧊📄§ | 2026-03-10 | 2044-07-02 | 0 | 31 |
| 12570709 | Self-assembling peptide amphiphiles displaying a transforming growth factor beta 1 (TGF-ß1) mimetic epitope | 🖼🧊📄§ | 2026-03-10 | 2042-07-28 | 0 | 31 |
| 12570759 | Polypeptides | 🖼🧊📄§ | 2026-03-10 | 2039-12-17 | 0 | 31 |
| 12570753 | Combination therapies with anti CD40 antibodies | 🖼🧊📄§ | 2026-03-10 | 2043-12-13 | 0 | 31 |
| 12569570 | Compositions and methods for targeted RNA delivery | 🖼🧊📄§ | 2026-03-10 | 2044-01-23 | 0 | 31 |
| 12569561 | Double stranded oligonucleotide construct comprising androgen receptor specific sequence, and composition for preventing hair loss and promoting hair growth comprising same | 🖼🧊📄§ | 2026-03-10 | 2039-11-18 | 0 | 31 |
| 12569431 | Immunostimulatory method | 🖼🧊📄§ | 2026-03-10 | 2043-10-10 | 0 | 31 |
| 12569450 | Nanoparticles for medical and diagnostic applications | 🖼🧊📄§ | 2026-03-10 | 2040-11-09 | 0 | 31 |
| 12569481 | Methods of treatment for gastrointestinal motility disorders | 🖼🧊📄§ | 2026-03-10 | 2041-06-11 | 0 | 31 |
| 12569506 | Methods of treating osteonecrosis with LLP2A-bisphosphonate compounds | 🖼🧊📄§ | 2026-03-10 | 2040-08-18 | 0 | 31 |
| 12568993 | Shelf-stable nitrogenous organic acid compositions | 🖼🧊📄§ | 2026-03-10 | 2038-10-18 | 0 | 31 |
| 12573050 | Systems and methods for platform agnostic whole body image segmentation | 🖼🧊📄§ | 2026-03-10 | 2044-01-31 | 0 | 31 |
| 12569628 | Delivery of medicinal gas in a liquid medium | 🖼🧊📄§ | 2026-03-10 | 2043-04-14 | 0 | 31 |
| 12569660 | Applicator head with dosing aid | 🖼🧊📄§ | 2026-03-10 | 2041-08-25 | 0 | 31 |
| 12569659 | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract | 🖼🧊📄§ | 2026-03-10 | 2044-01-22 | 0 | 31 |
| 12565526 | Formulations of anti-RSV antibodies and methods of use thereof | 🖼🧊📄§ | 2026-03-03 | 2039-10-14 | 0 | 31 |
| 12564739 | Engineered natural killer (NK) cells and compositions and methods thereof | 🖼🧊📄§ | 2026-03-03 | 2044-01-31 | 0 | 31 |
| 12564566 | Uses of long-chain polyunsaturated fatty acids | 🖼🧊📄§ | 2026-03-03 | 2040-08-07 | 0 | 31 |
| 12565521 | Systems, kits, and methods for forming in situ silk fibroin fibers and/or aerosols | 🖼🧊📄§ | 2026-03-03 | 2043-11-03 | 0 | 31 |
| 12565535 | Chimeric antigen receptors targeted to PSCA | 🖼🧊📄§ | 2026-03-03 | 2042-08-17 | 0 | 31 |
| 12564638 | EGFR protein degradant and anti-tumor application thereof | 🖼🧊📄§ | 2026-03-03 | 2040-08-05 | 0 | 31 |
| 12564630 | Vaccine adjuvants | 🖼🧊📄§ | 2026-03-03 | 2041-05-04 | 0 | 31 |
| 12564621 | Interleukin-18 variants and methods of use | 🖼🧊📄§ | 2026-03-03 | 2043-11-03 | 0 | 31 |
| 12564549 | Cleanser composition | 🖼🧊📄§ | 2026-03-03 | 2041-03-26 | 0 | 31 |
| 12564557 | Dual release dosage form capsule and methods, devices and systems for making same | 🖼🧊📄§ | 2026-03-03 | 2044-04-02 | 0 | 31 |
| 12564583 | Small molecules against cereblon to enhance effector T cell function | 🖼🧊📄§ | 2026-03-03 | 2042-06-07 | 0 | 31 |
| 12564589 | Methods for treating cancer, reducing side effects of cancer treatment, and preventing the recurrence of cancer | 🖼🧊📄§ | 2026-03-03 | 2045-03-18 | 0 | 31 |
| 12564591 | HCK as a therapeutic target in MYD88 mutated diseases | 🖼🧊📄§ | 2026-03-03 | 2040-10-07 | 0 | 31 |
| 12564601 | Methods for treating hepatitis B infection | 🖼🧊📄§ | 2026-03-03 | 2042-02-02 | 0 | 31 |
| 12565639 | Methods for differentiating dopaminergic neurons from stem cells | 🖼🧊📄§ | 2026-03-03 | 2044-06-13 | 0 | 31 |
| 12565649 | Methods of rescuing stop codons via genetic reassignment with ACE-tRNA | 🖼🧊📄§ | 2026-03-03 | 2043-04-21 | 0 | 31 |
| 12565533 | Agonistic CD40 antibodies | 🖼🧊📄§ | 2026-03-03 | 2043-05-25 | 0 | 31 |
| 12564645 | Methods for treatment of methylmalonic acidemia | 🖼🧊📄§ | 2026-03-03 | 2039-09-13 | 0 | 31 |
| 12565522 | Micropeptide HMMW and application thereof | 🖼🧊📄§ | 2026-03-03 | 2040-11-03 | 0 | 31 |
| 12564586 | Kappa opiod receptor antagonists for treating pain-related sleep disorders | 🖼🧊📄§ | 2026-03-03 | 2041-04-09 | 0 | 31 |